Debt-to-equity of UNITED THERAPEUTICS Corp from 30 Jun 2012 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
UNITED THERAPEUTICS Corp quarterly Debt-to-equity in % history and change rate from 30 Jun 2012 to 31 Dec 2025.
  • UNITED THERAPEUTICS Corp Debt-to-equity for the quarter ending 31 Dec 2025 was 12%, a 34% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

UNITED THERAPEUTICS Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 12% -5.9% -34% 31 Dec 2025
Q3 2025 12% -6.6% -35% 30 Sep 2025
Q2 2025 14% -7% -34% 30 Jun 2025
Q1 2025 16% -6.3% -29% 31 Mar 2025
Q4 2024 17% -4.9% -22% 31 Dec 2024
Q3 2024 19% -5% -21% 30 Sep 2024
Q2 2024 21% -4.4% -17% 30 Jun 2024
Q1 2024 22% -4.2% -16% 31 Mar 2024
Q4 2023 22% -4.9% -18% 31 Dec 2023
Q3 2023 24% -4.4% -16% 30 Sep 2023
Q2 2023 25% -4.8% -16% 30 Jun 2023
Q1 2023 26% -4.7% -15% 31 Mar 2023
Q4 2022 27% -5.2% -16% 31 Dec 2022
Q3 2022 28% -5.4% -16% 30 Sep 2022
Q2 2022 30% -4.8% -14% 30 Jun 2022
Q1 2022 31% -4.4% -13% 31 Mar 2022
Q4 2021 32% -3.3% -9.2% 31 Dec 2021
Q3 2021 34% -3% -8.3% 30 Sep 2021
Q2 2021 34% -5.5% -14% 30 Jun 2021
Q1 2021 35% -8.5% -19% 31 Mar 2021
Q4 2020 36% -14% -28% 31 Dec 2020
Q3 2020 37% -7.4% -17% 30 Sep 2020
Q2 2020 40% +1.3% +3.3% 30 Jun 2020
Q1 2020 44% +12% +36% 31 Mar 2020
Q4 2019 50% +25% +100% 31 Dec 2019
Q3 2019 44% +16% +57% 30 Sep 2019
Q2 2019 39% +6.9% +22% 30 Jun 2019
Q1 2019 32% -5.4% -14% 31 Mar 2019
Q4 2018 25% -12% -33% 31 Dec 2018
Q3 2018 28% -6.4% -18% 30 Sep 2018
Q2 2018 32% +1.8% +5.8% 30 Jun 2018
Q1 2018 38% +14% +63% 31 Mar 2018
Q4 2017 37% +13% +55% 31 Dec 2017
Q3 2017 35% +7.9% +30% 30 Sep 2017
Q2 2017 30% -2.2% -6.7% 30 Jun 2017
Q1 2017 23% -18% -44% 31 Mar 2017
Q4 2016 24% -29% -54% 31 Dec 2016
Q3 2016 27% -30% -53% 30 Sep 2016
Q2 2016 32% -32% -50% 30 Jun 2016
Q1 2016 42% -22% -35% 31 Mar 2016
Q4 2015 53% -7.8% -13% 31 Dec 2015
Q3 2015 57% -6.5% -10% 30 Sep 2015
Q2 2015 65% +6.7% +11% 30 Jun 2015
Q1 2015 64% +9.5% +17% 31 Mar 2015
Q4 2014 60% +8.8% +17% 31 Dec 2014
Q3 2014 64% +15% +32% 30 Sep 2014
Q2 2014 58% +8.5% +17% 30 Jun 2014
Q1 2014 54% +3.8% +7.5% 31 Mar 2014
Q4 2013 52% -0.21% -0.4% 31 Dec 2013
Q3 2013 48% -6.1% -11% 30 Sep 2013
Q2 2013 49% -4.5% -8.3% 30 Jun 2013
Q1 2013 51% 31 Mar 2013
Q4 2012 52% 31 Dec 2012
Q3 2012 54% 30 Sep 2012
Q2 2012 54% 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.